![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 8329-8337, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the § Division of Hematology, Department of
Medicine, and the ¶ Department of Biochemistry, Jichi Medical
School, Tochigi 329-04 and the Thrombopoietin (TPO), an essential factor for
megakaryopoiesis and thrombopoiesis, works as a survival factor for
megakaryocytic lineage cells. However, little is known about the
molecular mechanism in detail. We show here that TPO supports the
survival of TPO-dependent leukemia cell line UT-7/TPO and
normal megakaryocytic progenitors via the induction of Bcl-xL, an
anti-apoptotic member of the Bcl-2 family. We further analyzed the
signal transduction pathways required for TPO-induced Bcl-xL gene
expression. A reporter assay with various lengths of Bcl-x gene
promoter revealed that both Stat- and nuclear factor
Thrombopoietin Regulates Bcl-xL Gene Expression
through Stat5 and Phosphatidylinositol 3-Kinase Activation
Pathways*
,
Department of Internal Medicine
II, Hokkaido University School of Medicine,
Sapporo 060-8638, Japan
B-binding sites
are prerequisites for TPO-induced promoter activity. Consistent with
these results, TPO induced the binding of Stat5 and subunits of nuclear
factor
B, p50, and c-Rel to the Bcl-x gene promoter.
AG490, a specific inhibitor for Jak2, and LY294002, a specific
inhibitor for phosphatidylinositol (PI) 3-kinase, reduced the protein
level of Bcl-xL in UT-7/TPO cells, accompanied by an increase in the
ratio of apoptotic cells. Interestingly, LY294002 enhanced the
TPO-induced DNA binding activity of Stat5 without affecting the Jak2
activation and tyrosine phosphorylation of Stat5. Concomitantly,
confocal microscopy revealed that LY294002 clearly inhibited the
nuclear export of Stat5, suggesting that PI 3-kinase regulates the
subcellular localization of Stat5. Taken together, our results suggest
that both Jak-Stat and PI 3-kinase activation pathways regulate the
TPO-induced survival of megakaryocytic cells via Bcl-xL gene
expression. In addition, our data suggest possible cross-talk between
these two signaling pathways.
*
This work was supported by grants-in-aid for cancer research
and scientific research from the Ministry of Education, Science, Sports
and Culture of Japan and by grants from the Yamanouchi Foundation for
Research on Metabolic Disorders and Mochida Medical and Pharmaceutical
Foundation.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of
Hematology, Dept. of Medicine, Jichi Medical School,
Minamikawachi-machi, Tochigi-ken 329-0498, Japan. Tel.: 81-285-58-7353;
Fax: 81-285-44-5258; E-mail: nkomatsu@jichi.ac.jp.
This article has been cited by other articles:
![]() |
T.-L. Yue, S. S. Nerurkar, W. Bao, B. M. Jucker, L. Sarov-Blat, K. Steplewski, E. H. Ohlstein, and R. N. Willette In Vivo Activation of Peroxisome Proliferator-Activated Receptor-{delta} Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Kent, I. V. Glybina, G. W. Abrams, and R. Iezzi Chronic Intravitreous Infusion of Ciliary Neurotrophic Factor Modulates Electrical Retinal Stimulation Thresholds in the RCS Rat Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 372 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kanayasu-Toyoda, A. Ishii-Watabe, T. Suzuki, T. Oshizawa, and T. Yamaguchi A New Role of Thrombopoietin Enhancing ex Vivo Expansion of Endothelial Precursor Cells Derived from AC133-positive Cells J. Biol. Chem., November 16, 2007; 282(46): 33507 - 33514. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gobbi, P. Mirandola, I. Sponzilli, C. Micheloni, C. Malinverno, L. Cocco, and M. Vitale Timing and Expression Level of Protein Kinase C{varepsilon} Regulate the Megakaryocytic Differentiation of Human CD34 Cells Stem Cells, September 1, 2007; 25(9): 2322 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalakonda, S. C. Nallar, D. J. Lindner, J. Hu, S. P. Reddy, and D. V. Kalvakolanu Tumor-Suppressive Activity of the Cell Death Activator GRIM-19 on a Constitutively Active Signal Transducer and Activator of Transcription 3 Cancer Res., July 1, 2007; 67(13): 6212 - 6220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Ting, C.-W. Lin, S.-L. Wen, H.-M. Hsieh-Li, and H. Li Stat5 constitutive activation rescues defects in spinal muscular atrophy Hum. Mol. Genet., March 1, 2007; 16(5): 499 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ezzat, X. Zhu, S. Loeper, S. Fischer, and S. L. Asa Tumor-Derived Ikaros 6 Acetylates the Bcl-XL Promoter to Up-Regulate a Survival Signal in Pituitary Cells Mol. Endocrinol., November 1, 2006; 20(11): 2976 - 2986. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, N. Arimitsu, M. Takeuchi, N. Kawamura, M. Nagata, K. Saso, N. Akimitsu, H. Hamamoto, S. Natori, A. Miyajima, et al. Transcription Elongation Factor S-II Is Required for Definitive Hematopoiesis Mol. Cell. Biol., April 15, 2006; 26(8): 3194 - 3203. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Romanelli, I. Petrai, G. Robino, E. Efsen, E. Novo, A. Bonacchi, G. Pagliai, A. Grossi, M. Parola, N. Navari, et al. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G120 - G128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Drayer, S. G. M. Olthof, and E. Vellenga Mammalian Target of Rapamycin Is Required for Thrombopoietin-Induced Proliferation of Megakaryocyte Progenitors Stem Cells, January 1, 2006; 24(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kirito, N. Fox, N. Komatsu, and K. Kaushansky Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1{alpha} Blood, June 1, 2005; 105(11): 4258 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Drayer, A.-K. Boer, E. L. Los, M. T. Esselink, and E. Vellenga Stem Cell Factor Synergistically Enhances Thrombopoietin-Induced STAT5 Signaling in Megakaryocyte Progenitors through JAK2 and Src Kinase Stem Cells, February 1, 2005; 23(2): 240 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Paulus, N. Debili, F. Larbret, J. Levin, and W. Vainchenker Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors Blood, October 15, 2004; 104(8): 2291 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Bailey, K. M. Nieport, M. P. Herbst, S. Srivastava, R. A. Serra, and N. D. Horseman Prolactin and Transforming Growth Factor-{beta} Signaling Exert Opposing Effects on Mammary Gland Morphogenesis, Involution, and the Akt-Forkhead Pathway Mol. Endocrinol., May 1, 2004; 18(5): 1171 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Bradley, C. Couldrey, and K. D. Bunting Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness Blood, April 15, 2004; 103(8): 2965 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Okamura, N. Iwata, A. Nagata, A. Tamekane, M. Shimoyama, H. Gomyo, K. Yakushijin, N. Urahama, M. Hamaguchi, C. Fukui, et al. Involvement of casein kinase I{epsilon} in cytokine-induced granulocytic differentiation Blood, April 15, 2004; 103(8): 2997 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. L. Coluccia, S. Perego, L. Cleris, R. H. Gunby, L. Passoni, E. Marchesi, F. Formelli, and C. Gambacorti-Passerini Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo Blood, April 1, 2004; 103(7): 2787 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shibayama, E. Takai, I. Matsumura, M. Kouno, E. Morii, Y. Kitamura, J. Takeda, and Y. Kanakura Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis J. Exp. Med., February 17, 2004; 199(4): 581 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Rusinol, D. Thewke, J. Liu, N. Freeman, S. R. Panini, and M. S. Sinensky AKT/Protein Kinase B Regulation of BCL Family Members during Oxysterol-induced Apoptosis J. Biol. Chem., January 9, 2004; 279(2): 1392 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Irvin, L. D. Wood, L. Wang, R. Fenrick, C. G. Sansam, G. Packham, M. Kinch, E. Yang, and S. W. Hiebert TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL J. Biol. Chem., November 21, 2003; 278(47): 46378 - 46386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler Signal transducer and activator of transcription proteins in leukemias Blood, April 15, 2003; 101(8): 2940 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, T. Takasu, D. M. Perlman, M. S. Peterson, D. Burrichter, S. Avdulov, P. B. Bitterman, and V. A. Polunovsky Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochrome c Release J. Biol. Chem., January 24, 2003; 278(5): 3015 - 3022. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |